229 related articles for article (PubMed ID: 32733792)
1. High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.
Coto-Llerena M; Ercan C; Kancherla V; Taha-Mehlitz S; Eppenberger-Castori S; Soysal SD; Ng CKY; Bolli M; von Flüe M; Nicolas GP; Terracciano LM; Fani M; Piscuoglio S
Front Oncol; 2020; 10():979. PubMed ID: 32733792
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.
Greimelmaier K; Klopp N; Mairinger E; Wessolly M; Borchert S; Steinborn J; Schmid KW; Wohlschlaeger J; Mairinger FD
Pathol Oncol Res; 2023; 29():1611163. PubMed ID: 37614665
[No Abstract] [Full Text] [Related]
4. Identifying the oncogenic roles of FAP in human cancers based on systematic analysis.
Ma C; Xi S; Sun H; Zhang M; Pei Y
Aging (Albany NY); 2023 Jul; 15(14):7056-7083. PubMed ID: 37490719
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.
Kalaei Z; Manafi-Farid R; Rashidi B; Kiani FK; Zarei A; Fathi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Jun; 21(1):139. PubMed ID: 37316886
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
Hu M; Qian C; Hu Z; Fei B; Zhou H
OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
[TBL] [Abstract][Full Text] [Related]
8. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
Chen L; Qiu X; Wang X; He J
Biochem Biophys Res Commun; 2017 May; 487(1):8-14. PubMed ID: 28302482
[TBL] [Abstract][Full Text] [Related]
9. Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Ma TH; Gao CC; Xie R; Yang XZ; Dai WJ; Zhang JL; Yan W; Wu SN
Neoplasma; 2017; 64(6):880-886. PubMed ID: 28895412
[TBL] [Abstract][Full Text] [Related]
10. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.
Meng M; Wang W; Yan J; Tan J; Liao L; Shi J; Wei C; Xie Y; Jin X; Yang L; Jin Q; Zhu H; Tan W; Yang F; Hou Z
Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F; Qi L; Liu B; Liu J; Zhang H; Che D; Cao J; Shen J; Geng J; Bi Y; Ye L; Pan B; Yu Y
PLoS One; 2015; 10(3):e0116683. PubMed ID: 25775399
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
14. Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures.
Marquardt A; Hartrampf P; Kollmannsberger P; Solimando AG; Meierjohann S; Kübler H; Bargou R; Schilling B; Serfling SE; Buck A; Werner RA; Lapa C; Krebs M
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672341
[TBL] [Abstract][Full Text] [Related]
15. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence.
Hayase S; Miyoshi N; Fujino S; Yasui M; Ohue M; Minami S; Kato S; Nagae A; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
Anticancer Res; 2022 Dec; 42(12):5897-5907. PubMed ID: 36456145
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of fibroblast activation protein in colorectal carcinoma tissue].
Cui B; Wang QW; Fang R; Du J; Zhang JM
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):392-5. PubMed ID: 22539390
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of fibroblast activation protein-α in human lung adenocarcinoma.
Shi J; Hou Z; Yan J; Qiu W; Liang L; Meng M; Li L; Wang X; Xie Y; Jiang L; Wang W
Ann Transl Med; 2020 Mar; 8(5):224. PubMed ID: 32309371
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]